Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00260663 · ClinicalTrials.gov registry record · NA

The Hearing Aid Effectiveness After Aural Rehabilitation (HEAR) Trial

A NA study of Hearing Loss, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
660
Enrollment target
1
Study location

NCT00260663: Completed NA study of Hearing Loss, sponsored by US Department of Veterans Affairs.

NCT00260663 is a NA study of Hearing Loss that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 660 participants, below the 6,110-participant average among 58 other Hearing Loss trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00260663, a NA study of Hearing Loss, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
660 participants
Enrollment target
1
Study location

Study Summary

This study compares the effectiveness of hearing aid appointments provided in a group format to those provided in an individual format. We are asking if hearing aid training with group appointments is as good as or better than with individual appointments.

Conditions Studied

Interventions

  • PROCEDURE Group hearing aid fittings
  • PROCEDURE Group hearing aid follow-up

Study Locations (1)

Washington

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle

Trial Details

FieldValue
Enrollment Target 660 participants
Start Date 2006-02
Est. Completion 2008-06
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00260663 record still lists

NCT00260663 is an interventional study that assigns participants to a tested intervention. The registered 660 participants enrollment target is mid-sized for trials with a published cap, below the 6,110-participant average among 58 other Hearing Loss trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Group hearing aid fittings is the first listed.

NCT00260663 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT00260663 about?

NCT00260663 is a clinical study titled "The Hearing Aid Effectiveness After Aural Rehabilitation (HEAR) Trial". This study compares the effectiveness of hearing aid appointments provided in a group format to those provided in an individual format. We are asking if hearing aid training with group appointments is as good as or better than with individual appointments.

What is the current status of trial NCT00260663?

This trial is currently completed. It is a NA study. The enrollment target is 660 participants. The study started on 2006-02. Estimated completion is 2008-06.

What conditions does trial NCT00260663 study?

This clinical trial studies the following conditions: Hearing Loss.

What interventions are being tested in trial NCT00260663?

The interventions under investigation include: Group hearing aid fittings (PROCEDURE), Group hearing aid follow-up (PROCEDURE).

Who is sponsoring clinical trial NCT00260663?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00260663 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00260663's enrollment target sits among peer trials

660 11th of 58 higher than 48 of 58 other Hearing Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01185132 · 660 participants · Phase 3

    Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

  • NCT03346694 · 660 participants · NA

    Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing

  • NCT05407636 · 660 participants · Phase 3

    Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

  • NCT05470205 · 660 participants · Phase 3

    Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00260663, the US trial registry maintained by the National Library of Medicine. NCT00260663 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.